[PLX] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
16-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 59.47%
YoY- 50.65%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 8,617 14,183 8,753 16,085 8,549 12,054 6,427 21.52%
PBT -3,210 -3,567 -5,334 -2,286 -6,667 -4,199 -11,241 -56.53%
Tax 530 442 -190 416 908 96 128 157.18%
NP -3,740 -4,009 -5,144 -2,702 -6,667 -4,199 -11,241 -51.88%
Tax Rate - - - - - - - -
Total Cost 12,357 18,192 13,897 18,787 15,216 16,253 17,668 -21.15%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -43.40 -28.27 -58.77 -16.80 -77.99 -34.83 -174.90 -60.41%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.07 -0.08 -0.11 -0.06 -0.15 -0.09 -0.25 -57.10%
EPS Diluted -0.07 -0.08 -0.11 -0.06 -0.15 -0.09 -0.25 -57.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.